identif
caus
microorgan
childhood
cap
remain
ongo
challeng
affect
type
clinic
specimen
obtain
test
method
use
previou
studi
use
varieti
specimen
identifi
caus
pathogen
childhood
pneumonia
includ
bronchoalveolar
lung
fluid
blood
nasopharyng
aspir
nasopharyng
swab
pleural
fluid
complic
case
varieti
respiratori
virus
bacteria
associ
childhood
cap
develop
tabl
pathogen
fungi
includ
endem
mycos
less
common
caus
histor
bacteria
consid
import
caus
cap
children
global
prior
introduct
pneumococc
conjug
vaccin
pcv
develop
countri
earli
streptococcu
pneumonia
pneumococcu
lead
bacteri
pathogen
caus
cap
identifi
young
children
bacteria
associ
childhood
pneumonia
includ
encapsul
nontyp
haemophilu
influenza
streptococcu
pyogen
staphylococcu
aureu
moraxella
gramneg
enter
bacteria
atyp
intracellular
bacteria
exampl
mycoplasma
pneumonia
chlamydophila
pneumonia
also
report
caus
childhood
pneumonia
appear
detect
commonli
among
school
age
younger
burden
bacteri
pneumonia
reduc
significantli
europ
usa
australia
sinc
introduct
conjug
h
influenza
b
multival
pcv
routin
immunis
howev
bacteria
still
remain
import
caus
pneumonia
mani
develop
set
vaccin
introduc
recent
develop
frequent
use
molecular
diagnost
respiratori
virus
increasingli
detect
among
children
pneumonia
particularli
children
year
among
virus
respiratori
syncyti
viru
rsv
influenza
viru
human
parainfluenza
viru
hpiv
human
rhinoviru
hrv
human
adenoviru
hadv
commonli
detect
children
pneumonia
new
sensit
molecular
techniqu
enabl
detect
new
respiratori
virus
includ
human
metapneumoviru
hmpv
novel
human
coronaviru
hcov
human
bocaviru
emerg
strain
influenza
viru
childhood
develop
countri
young
children
cap
virus
detect
respiratori
specimen
rsv
frequent
detect
viru
studi
rang
evid
respiratori
virus
may
role
facilit
bacteri
colonis
enhanc
bacteri
infect
andor
enhanc
diseas
sever
either
directli
indirectli
virus
disrupt
respiratori
epithelium
barrier
also
alter
defenc
mechan
host
epithelium
potenti
lead
bacteri
entranc
enabl
secondari
bacteri
incid
invas
pneumococc
infect
observ
higher
increas
season
activ
respiratori
virus
includ
influenza
rsv
parainfluenza
clinic
trial
south
africa
conjug
pneumococc
vaccin
result
overal
decreas
virusassoci
pneumonia
suggest
interact
respiratori
virus
pneumococcu
caus
pneumonia
australia
ecolog
data
demonstr
reduct
viral
pneumonia
follow
introduct
pcv
rsv
report
facilit
bacteri
colonis
h
influenza
streptococcu
pyogen
staphylococcu
aureu
catarrhali
nasopharynx
young
children
acut
respiratori
anoth
studi
australia
identifi
streptococcu
pneumonia
h
influenza
staphylococcu
aureu
patient
intens
care
admit
sever
influenza
infect
influenza
patient
coinfect
report
suffer
treatment
failur
longer
ventil
support
increas
likelihood
intens
care
unit
relationship
nasopharyng
pathogen
load
diseas
sever
previous
assess
data
sever
pneumonia
epidemiolog
studi
studi
demonstr
nasopharyng
pathogen
load
could
predict
sever
pneumonia
children
studi
usa
among
infant
report
higher
rsv
load
associ
longer
hospitalis
respiratori
failur
admiss
intens
care
vietnam
children
radiolog
confirm
pneumonia
higher
pneumococc
load
compar
children
respiratori
ill
load
pneumococcu
higher
children
viral
coinfect
compar
viral
studi
kenya
netherland
report
higher
nasopharyng
rsv
load
children
sever
respiratori
infect
compar
less
sever
despit
number
studi
develop
countri
design
explor
aetiolog
acut
respiratori
infect
children
includ
cap
includ
healthyasymptomat
children
studi
includ
healthi
control
identifi
asymptomat
presenc
pathogen
known
associ
pneumonia
tabl
addit
epidemiolog
studi
similar
set
nasopharyng
carriag
respiratori
bacteria
virus
known
associ
pneumonia
also
report
healthi
togeth
find
suggest
asymptomat
carriag
may
common
healthi
popul
therebi
make
interpret
cap
studi
challeng
although
pcv
success
reduc
hospitalis
rate
cap
children
develop
countri
pneumococcu
remain
import
pathogen
emerg
nonvaccin
serotyp
potenti
caus
sever
complic
pneumonia
mani
case
associ
respiratori
virus
tabl
current
immunis
strategi
focuss
exclus
bacteri
pneumonia
expect
modest
impact
pneumonia
case
reduct
apart
annual
influenza
vaccin
date
licens
vaccin
respiratori
virus
use
commun
critic
understand
rel
contribut
specif
bacteri
viral
pathogen
childhood
cap
help
inform
develop
new
therapeut
pneumonia
includ
antivir
support
ongo
effort
new
prevent
strategi
vaccin
target
rsv
parainfluenza
advanc
stage
develop
question
constitut
primari
aim
studi
addit
unveil
relationship
pathogen
load
pathogen
inform
tool
accur
attribut
infect
caus
cap
allow
better
diagnosi
manag
pneumonia
case
use
antibiot
antivir
therapi
final
studi
identifi
emerg
serotyp
pneumococcu
caus
cap
among
vaccin
children
inform
design
futur
pneumococc
vaccin
detect
microorgan
asymptomat
children
make
challeng
ascertain
exact
contribut
pathogen
diseas
uncontrol
pneumonia
aetiolog
studi
cap
studi
children
develop
countri
generalis
develop
countri
like
australia
health
infrastructur
includ
access
vaccin
much
recent
find
two
publish
studi
childhood
pneumonia
develop
countri
one
usa
sweden
limit
tabl
jain
et
al
rhedin
et
al
swedish
studi
rel
underpow
xray
confirm
case
control
assess
attribut
risk
rang
viral
pathogen
us
studi
healthi
control
enrol
contemporan
studi
site
might
bias
infer
specif
pathogen
propos
studi
first
studi
pneumonia
aetiolog
australia
post
pcv
vaccin
era
radiolog
confirm
hospitalis
pneumonia
case
compar
age
group
frequencymatch
healthi
control
presenc
respiratori
pathogen
quantit
load
pathogen
propos
studi
expect
address
limit
previou
studi
recruit
appropri
number
case
control
contemporan
studi
site
prospect
studi
name
pneumowa
studi
ratio
children
attend
publicli
fund
health
servic
metropolitan
perth
western
australia
recruit
enrol
children
studi
commenc
princess
margaret
hospit
children
pmh
perth
western
australia
may
case
control
enrol
follow
inclus
exclus
criteria
studi
tabl
case
defin
children
attend
pmh
cap
identifi
treat
clinician
oper
definit
pneumonia
studi
presenc
one
follow
clinic
symptom
cough
fever
increas
work
breath
b
alveolar
consolid
judg
treat
clinician
paediatr
radiologist
c
presum
infect
aetiolog
requir
antibiot
therapi
control
group
consist
contemporan
healthi
children
attend
pmh
outpati
clinic
local
commun
immunis
clinic
sign
respiratori
ill
total
case
control
enrol
power
studi
detect
significantli
higher
rate
pathogen
detect
among
case
versu
control
depend
frequenc
pathogen
detect
healthi
control
use
data
previous
publish
literatur
among
pneumonia
case
healthi
estim
sampl
size
pneumonia
case
healthi
control
would
provid
power
identifi
signific
excess
pathogen
detect
lower
bound
ci
among
case
compar
control
rang
least
influenza
rhinoviru
case
identifi
daili
monitor
present
emerg
depart
ed
admiss
record
pmh
assess
inclus
exclus
criteria
parent
approach
train
research
assist
consent
enrol
follow
data
biolog
specimen
collect
control
enrol
prospect
contemporan
train
research
staff
attend
pmh
outpati
clinic
rheola
street
immunis
clinic
perth
western
australia
parent
approach
await
child
medic
appoint
routin
immunis
control
frequenc
match
case
age
group
year
year
year
year
prospect
set
target
control
enrol
base
number
case
enrol
age
group
preced
week
follow
consent
epidemiolog
data
relat
pertin
demograph
factor
age
sex
indigen
statu
presenc
smoker
household
prematur
birth
preexist
chronic
health
condit
immunodefici
neurolog
disord
chronic
cardiac
diseas
collect
studi
particip
tabl
use
standardis
paperbas
data
collect
form
interview
parent
data
clinic
manag
diseas
outcom
case
obtain
review
hospit
medic
record
patient
medic
record
file
revisit
obtain
miss
medic
inform
ill
episod
immunis
record
child
collect
australian
immunis
record
air
particip
alloc
uniqu
identif
number
allow
anonymis
data
enter
onto
secur
webbas
research
databas
medrio
nasopharyng
swab
np
collect
case
control
use
floqswab
copan
diagnost
murrieta
california
usa
train
research
staff
follow
recommend
collect
swab
store
ml
skim
broth
suitabl
storag
transport
respiratori
bacteria
specimen
recommend
mandat
includ
blood
cultur
edta
blood
pneumococc
pcr
set
pleural
effus
cultur
pneumococc
pcr
also
recommend
despit
sensit
specif
lung
aspir
undertaken
pneumowa
given
invas
natur
risk
collect
np
specimen
kept
ice
process
within
hour
research
laboratori
pmh
children
clinic
research
facil
np
specimen
vortex
divid
two
aliquot
bacteri
viral
assess
vial
store
specimen
batch
period
sent
refer
laboratori
pcr
test
np
specimen
transport
refer
laboratori
ice
day
test
avoid
addit
cycl
np
test
viral
presenc
load
pathwest
laboratori
medicin
wa
perth
australia
bacteri
load
research
laboratori
school
biomed
scienc
univers
western
australia
perth
western
australia
respiratori
virus
atyp
bacteri
pathogen
pneumonia
c
pneumonia
detect
multiplex
realtim
pcr
pathwest
laboratori
qeii
use
previous
describ
primer
detail
nucleic
acid
extract
np
use
magna
pure
system
roch
appli
scienc
indianapoli
indiana
usa
extract
nucleic
acid
test
appli
biosystem
realtim
pcr
system
thermofish
scientif
massachusett
usa
common
respiratori
viru
panel
includ
influenza
influenza
b
hpiv
type
hmpv
rsv
type
b
target
hadv
hcov
hcov
hcov
hcov
hrv
atyp
bacteria
set
qiagen
rotorgen
taqman
analys
realtim
pcr
pcr
assay
direct
nontransl
region
hrv
speci
use
distinguish
rhinovirus
enteroviru
speci
adapt
osterback
et
al
merritt
et
al
quantit
viral
load
assess
np
specimen
posit
respiratori
virus
primer
probe
protocol
determin
viral
load
rang
viral
pathogen
np
specimen
develop
pathwest
sikazw
et
al
unpublish
data
nucleic
acid
standard
develop
use
purifi
plasmid
dna
vitro
transcrib
rna
concentr
dna
andor
rna
standard
quantifi
use
fluoresc
dye
follow
standard
curv
gener
serial
dilut
dna
andor
rna
standard
mention
viral
load
np
specimen
quantifi
interpol
appropri
standard
curv
viral
load
report
viral
copiesml
quantif
bacteri
load
np
specimen
perform
use
quantit
realtim
pcr
qpcr
use
method
establish
uwa
school
biomed
scienc
kirkham
et
al
unpublish
data
np
stgg
centrifug
high
speed
pellet
bacteria
associ
cell
dna
extract
pellet
use
enzymat
extract
qiaamp
dna
minikit
qiagen
chadston
vic
australia
previous
realtim
qpcr
detect
pneumonia
aureu
catarrhali
nontyp
h
influenza
conduct
realtim
pcr
detect
system
biorad
california
usa
use
primer
probe
list
tabl
standard
curv
gener
run
refer
strain
sampl
run
duplic
densiti
calcul
averag
two
measur
bacteri
load
assess
coloni
form
unit
cfu
ml
equival
copiesml
assum
one
copi
bacteria
would
yield
one
coloni
form
unit
frequenc
proport
posit
respiratori
pathogen
among
case
control
assess
number
permit
viru
subtyp
report
separ
proport
compar
across
two
group
identifi
specif
pathogen
detect
frequent
among
case
among
control
report
crude
detect
respiratori
pathogen
among
cap
case
versu
control
also
report
adjust
pathogen
adjust
demograph
factor
eg
age
sex
presenc
smoker
household
prematur
birth
presenc
pathogen
use
multivari
logist
regress
refer
model
adjust
detect
among
case
versu
control
taken
indic
pathogen
organ
higher
higher
indic
pathogen
microorgan
use
proport
case
infect
adjust
pathogen
popul
level
attribut
fraction
cap
calcul
use
method
greenland
frequenc
proport
case
control
one
respiratori
viru
bacteria
detect
report
number
permit
multivari
regress
model
develop
explor
exist
signific
pairwis
interact
respiratori
pathogen
diseas
statu
diseas
sever
case
assess
use
respiratori
index
sever
children
score
base
australian
children
growth
number
permit
explor
relationship
detect
specif
pathogen
sever
diseas
vs
control
statu
use
multivari
logist
regress
model
describ
model
model
report
median
logtransform
pathogen
load
pathogen
case
control
compar
use
student
ttest
mannwhitney
u
test
method
whichev
applic
determin
pathogen
load
differ
case
control
multivari
regress
analysi
model
perform
determin
odd
case
increas
pathogen
loadml
viral
bacteri
pathogen
adjust
demograph
factor
number
permit
approach
use
determin
increas
odd
sever
pneumonia
vs
control
statu
model
explor
curv
correspond
area
curv
find
optim
load
cutpoint
sensit
specif
discrimin
cap
case
control
sever
cap
nonsever
cap
also
analys
data
use
classif
regress
tree
bayesian
network
method
altern
approach
select
threshold
level
pathogen
load
discrimin
case
control
analys
perform
use
stata
softwar
written
inform
consent
obtain
parent
assent
children
year
prior
administr
questionnair
biolog
specimen
collect
risk
benefit
relat
particip
studi
clearli
inform
parent
children
obtain
consent
uniqu
identif
number
provid
particip
ensur
anonym
inform
collect
studi
particip
remain
confidenti
payment
compens
associ
particip
find
dissemin
nation
intern
confer
health
symposium
manuscript
detail
result
studi
submit
public
peerreview
journal
find
studi
would
describ
attribut
risk
specif
viral
bacteri
pathogen
caus
childhood
pneumonia
popul
level
might
help
effici
diagnosi
manag
lower
respiratori
tract
infect
lrti
includ
pneumonia
children
could
reduc
inappropri
antibiot
treat
lrti
